Literature DB >> 31107317

CORR Insights®: High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.

Michelle Ghert1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31107317      PMCID： PMC6999990          DOI： 10.1097/CORR.0000000000000777

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  10 in total

1.  High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study.

Authors:  Olivier Q Groot; Paul T Ogink; Nuno Rei Paulino Pereira; Marco L Ferrone; Mitchell B Harris; Santiago A Lozano-Calderon; Andrew J Schoenfeld; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

Review 2.  Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.

Authors:  Soheir S Adam; Jennifer R McDuffie; Paul F Lachiewicz; Thomas L Ortel; John W Williams
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

Review 3.  New anticoagulants, reversal agents, and clinical considerations for perioperative practice.

Authors:  Brendon M Hart; Stephane M Ferrell; Mark W Motejunas; Lauren A Bonneval; Elyse M Cornett; Richard D Urman; Alan D Kaye
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2018-07-03

4.  Beyond prophylaxis: Extended risk of venous thromboembolism following primary debulking surgery for ovarian cancer.

Authors:  Beth E Wagner; Carrie L Langstraat; Michaela E McGree; Amy L Weaver; Shikha Sarangi; Bahareh Mokri; Sean C Dowdy; William A Cliby; Amanika Kumar; Jamie N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2018-11-22       Impact factor: 5.482

5.  Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.

Authors:  Ang Li; David A Garcia; Gary H Lyman; Marc Carrier
Journal:  Thromb Res       Date:  2018-03-02       Impact factor: 3.944

6.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

7.  Complications and reoperations after surgery for 647 patients with spine metastatic disease.

Authors:  Nuno Rui Paulino Pereira; Paul T Ogink; Olivier Q Groot; Marco L Ferrone; Francis J Hornicek; C N van Dijk; J A M Bramer; Joseph H Schwab
Journal:  Spine J       Date:  2018-06-01       Impact factor: 4.166

Review 8.  Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.

Authors:  Antonio Gómez-Outes; Ana Isabel Terleira-Fernández; M Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  BMJ       Date:  2012-06-14

Review 9.  Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Authors:  Charbel F Matar; Lara A Kahale; Maram B Hakoum; Ibrahim G Tsolakian; Itziar Etxeandia-Ikobaltzeta; Victor Ed Yosuico; Irene Terrenato; Francesca Sperati; Maddalena Barba; Holger Schünemann; Elie A Akl
Journal:  Cochrane Database Syst Rev       Date:  2018-07-11

10.  Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.

Authors:  Guang-Zhi Ning; Shun-Li Kan; Ling-Xiao Chen; Lei Shangguan; Shi-Qing Feng; Yue Zhou
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.